Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 26 February 2014 | By Alexander Gaffney, RAC,
Australian regulators with its Therapeutic Goods Administration (TGA) have announced that they will soon adopt an electronic system capable of receiving drug applications without the use of paper.
TGA first announced its intent to move forward with the transition in October 2013. At present, TGA receives all of its submissions in paper format, which is expensive for industry to create and regulators to store. New drug applications can be tens, and often hundreds of thousands of pages in total length.
As global regulators, including the US Food and Drug Administration (FDA), often attest, digital copies of applications are cheaper to generate and store, but also allow for faster, easier and better analysis of applications.
At the core of most electronic drug submissions systems is the electronic common technical document (eCTD), a digital module-based regulatory application form developed and maintained by the International Conference on Harmonisation (ICH). The basic premise of the eCTD is to harmonize the layout and format of pharmaceutical submission documents to the extent possible to allow for easier and faster filing and reviews of applications.
The eCTD is already used by FDA, the European Medicines Agency (EMA) and Japan's Ministry of Health, Labour and Welfare (MHLW). In the US, use of the electronic standard is set to soon become mandatory.
But for whatever reason, Australia has been slow to fully adopt the electronic standard.
Current applications to TGA are submitted in both paper and electronic format, which TGA acknowledged is costly and difficult to process. Though the electronic forms allow for somewhat easier processing, the hard copy submitted to TGA is deemed to be the, "Authoritative source of data supporting a regulatory application."
At the time, TGA said it was planning to work closely with the pharmaceutical industry to establish an eCTD framework and to develop an implementation timetable.
Now that system is coming online. In a 26 February 2014 announcement, TGA said it has adopted Lorenz' docuBridge software platform to receive, review and process electronic applications for prescription medicines regulated under its Register of Therapeutic Goods (ARTG).
"The TGA looks forward to working with stakeholders throughout 2014 to introduce this system that will improve the quality and reduce the cost of medicines applications to the TGA," it said, adding that it will work with industry throughout the coming year to ensure a smooth transition.
The new system will not require companies to submit paper documentation at all, it explained.
TGA Statement
Tags: Electronic Common Technical Document, eCTD, australia
Regulatory Focus newsletters
All the biggest regulatory news and happenings.